ArticleOphthalmology and therapy2023

Trends in the Cumulative Post-Marketing Reporting Rates of Retinal Vasculitis and/or Retinal Vascular Occlusion and Associated Vision Loss with Brolucizumab.

Franklin Igwe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.